BOSTON, Nov. 3 Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received purchase orders for its MammoView(TM) line of surgical endoscopy instruments from various hospitals under Catholic Health Initiatives, Littleton, CO. Catholic Health Initiatives is constructed of seventy-eight hospitals, including twenty-two critical-access facilities and thirty rural hospitals that are the sole providers of health care in their communities.
Catholic Health Initiatives is a national nonprofit health care system with headquarters in Denver. The second-largest faith-based health care system in the nation, Catholic Health Initiatives was formed in 1996 through the alliance of four Catholic health systems seeking to strengthen and expand their health ministry for the future. It was the first Catholic system to give lay people a sponsorship role in its facilities. Today, Catholic Health Initiatives provides health care and other services to a diverse mix of sixty-nine urban and rural communities across the nation.
"We are delighted to be working with one of the best health care organizations in the United States by providing them the latest instrumentation for breast endoscopy," stated Bob Segersten, President of Solos Endoscopy, Inc.
Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its FDA approved MammoView(TM) line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.
For more information on Catholic Health Initiatives, please visit: www.catholichealthinit.org
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office with its catalog of FDA Approved products. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.